CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 138 filers reported holding CLOVIS ONCOLOGY INC in Q1 2014. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $63,000 | -17.1% | 10,800 | 0.0% | 0.00% | – |
| Q1 2021 | $76,000 | +46.2% | 10,800 | 0.0% | 0.00% | – |
| Q4 2020 | $52,000 | -17.5% | 10,800 | 0.0% | 0.00% | – |
| Q3 2020 | $63,000 | -95.7% | 10,800 | -97.1% | 0.00% | -100.0% |
| Q3 2019 | $1,478,000 | -45.1% | 376,000 | +107.6% | 0.00% | -66.7% |
| Q2 2019 | $2,693,000 | -25.6% | 181,100 | +24.2% | 0.01% | -25.0% |
| Q1 2019 | $3,619,000 | +106.7% | 145,800 | +49.5% | 0.01% | +100.0% |
| Q4 2018 | $1,751,000 | -21.4% | 97,500 | +28.5% | 0.00% | -20.0% |
| Q3 2018 | $2,229,000 | -87.2% | 75,900 | -80.2% | 0.01% | -88.1% |
| Q2 2018 | $17,417,000 | -1.2% | 383,034 | +14.7% | 0.04% | -2.3% |
| Q1 2018 | $17,632,000 | -35.1% | 333,930 | -16.5% | 0.04% | -38.6% |
| Q4 2017 | $27,182,000 | -10.1% | 399,734 | +8.9% | 0.07% | -18.6% |
| Q3 2017 | $30,243,000 | +85.5% | 367,029 | +16.3% | 0.09% | +72.0% |
| Q2 2017 | $16,307,000 | +37.1% | 315,663 | +69.0% | 0.05% | +28.2% |
| Q1 2017 | $11,894,000 | +37.1% | 186,811 | -4.3% | 0.04% | +21.9% |
| Q4 2016 | $8,675,000 | +497.5% | 195,285 | +1035.4% | 0.03% | +433.3% |
| Q2 2015 | $1,452,000 | -17.9% | 17,200 | -21.8% | 0.01% | -14.3% |
| Q1 2015 | $1,768,000 | -57.1% | 22,000 | -70.1% | 0.01% | -61.1% |
| Q4 2014 | $4,118,000 | +256.5% | 73,533 | +163.6% | 0.02% | +200.0% |
| Q2 2014 | $1,155,000 | -46.4% | 27,900 | -10.3% | 0.01% | -45.5% |
| Q1 2014 | $2,154,000 | +2.1% | 31,100 | -11.1% | 0.01% | 0.0% |
| Q4 2013 | $2,109,000 | +29.0% | 35,000 | +30.1% | 0.01% | +22.2% |
| Q3 2013 | $1,635,000 | +66.0% | 26,900 | +83.0% | 0.01% | +50.0% |
| Q2 2013 | $985,000 | – | 14,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |